Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabira Tahseen

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Plos One|February 11, 2016
Population Based National Tuberculosis Prevalence Survey among Adults (>15 Years) in Pakistan, 2010-2011Ejaz Qadeer, Razia Fatima, Aashifa Yaqoob, et al.
BMC Research Notes|May 28, 2011
Delay in diagnosis of tuberculosis in Rawalpindi, PakistanMuhammad An Saqib, Irum N Awan, Syed Ka Rizvi, et al.
Microbiology Spectrum|November 20, 2023
Phenotype versus genotype discordant rifampicin susceptibility testing in tuberculosis: implications for a diagnostic accuracyMehmood Qadir, Rani Faryal, Muhammad Tahir Khan, et al.
Journal of Immunoassay & Immunochemistry|December 4, 2013
Evaluation of diagnostic potential of Rv3803c and Rv2626c recombinant antigens in TB endemic country PakistanSajjad Ashraf, Muhammad Arif Nadeem Saqib, Mirza Zahid Sharif, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis ComplexRoger Vargas, Luca Freschi, Andrea Spitaleri, et al.
Antimicrobial Agents and Chemotherapy|July 3, 2019
Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in PakistanArash Ghodousi, Alamdar Hussain Rizvi, Aurangzaib Quadir Baloch, et al.
International Journal of Antimicrobial Agents|October 19, 2019
World Health Organization 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forwardArmand Van Deun, Tom Decroo, Sabira Tahseen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2024
Prospective Exploratory Evaluation of Cepheid Xpert Mycobacterium tuberculosis Host Response Cartridge: A Focus on Adolescents and Young AdultsMarva Seifert, Donald G Catanzaro, Michael Gracia, et al.
Frontiers in Microbiology|July 16, 2025
Identification of <i>Datura innoxia</i> as a potential source of antimycobacterial componentsSajjad Ahmed Khan, Muzafar Ahmad Rather, Muhammad Sheeraz Ahmad, et al.
Nature Communications|October 21, 2021
Population structure, biogeography and transmissibility of Mycobacterium tuberculosisLuca Freschi, Roger Vargas, Ashaque Husain, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Plos One|February 11, 2016
Population Based National Tuberculosis Prevalence Survey among Adults (>15 Years) in Pakistan, 2010-2011Ejaz Qadeer, Razia Fatima, Aashifa Yaqoob, et al.
BMC Research Notes|May 28, 2011
Delay in diagnosis of tuberculosis in Rawalpindi, PakistanMuhammad An Saqib, Irum N Awan, Syed Ka Rizvi, et al.
Microbiology Spectrum|November 20, 2023
Phenotype versus genotype discordant rifampicin susceptibility testing in tuberculosis: implications for a diagnostic accuracyMehmood Qadir, Rani Faryal, Muhammad Tahir Khan, et al.
Journal of Immunoassay & Immunochemistry|December 4, 2013
Evaluation of diagnostic potential of Rv3803c and Rv2626c recombinant antigens in TB endemic country PakistanSajjad Ashraf, Muhammad Arif Nadeem Saqib, Mirza Zahid Sharif, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis ComplexRoger Vargas, Luca Freschi, Andrea Spitaleri, et al.
Antimicrobial Agents and Chemotherapy|July 3, 2019
Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in PakistanArash Ghodousi, Alamdar Hussain Rizvi, Aurangzaib Quadir Baloch, et al.
International Journal of Antimicrobial Agents|October 19, 2019
World Health Organization 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forwardArmand Van Deun, Tom Decroo, Sabira Tahseen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2024
Prospective Exploratory Evaluation of Cepheid Xpert Mycobacterium tuberculosis Host Response Cartridge: A Focus on Adolescents and Young AdultsMarva Seifert, Donald G Catanzaro, Michael Gracia, et al.
Frontiers in Microbiology|July 16, 2025
Identification of <i>Datura innoxia</i> as a potential source of antimycobacterial componentsSajjad Ahmed Khan, Muzafar Ahmad Rather, Muhammad Sheeraz Ahmad, et al.
Nature Communications|October 21, 2021
Population structure, biogeography and transmissibility of Mycobacterium tuberculosisLuca Freschi, Roger Vargas, Ashaque Husain, et al.
Pageof 4